SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-051891
Filing Date
2024-06-12
Accepted
2024-06-12 08:00:35
Documents
18
Period of Report
2024-06-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0207631-8k_jasper.htm   iXBRL 8-K 58679
2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED AS OF JUNE 10, 2024, BY AND BET ea020763101ex10-3_jasper.htm EX-10.3 72399
3 AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED AS OF JUNE 10, 2024, BY AND BET ea020763101ex10-4_jasper.htm EX-10.4 73367
4 AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED AS OF JUNE 10, 2024, BY AND BET ea020763101ex10-5_jasper.htm EX-10.5 75576
5 AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED AS OF JUNE 10, 2024, BY AND BET ea020763101ex10-6_jasper.htm EX-10.6 94707
  Complete submission text file 0001213900-24-051891.txt   678600

Data Files

Seq Description Document Type Size
6 XBRL DEFINITION FILE jspr-20240606_def.xml EX-101.DEF 26833
7 XBRL LABEL FILE jspr-20240606_lab.xml EX-101.LAB 37093
8 XBRL PRESENTATION FILE jspr-20240606_pre.xml EX-101.PRE 25457
9 XBRL SCHEMA FILE jspr-20240606.xsd EX-101.SCH 3928
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0207631-8k_jasper_htm.xml XML 6109
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39138 | Film No.: 241037513
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)